Results
256
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
256 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SREV | US$1.50 | 0.7% | 2.0% | US$150.2m | n/a | PS0.8x | n/a | n/a | ||
AUR | US$6.98 | -12.6% | 59.7% | US$12.4b | US$5.35 | PB5.9x | E11.2% | n/a | ||
EPAM | US$243.80 | 0.2% | -17.8% | US$14.1b | US$258.74 | PE30.8x | E10.4% | n/a | ||
SKKY | US$0.70 | -11.4% | 74.9% | US$37.2m | n/a | PE1143.7x | n/a | n/a | ||
SDCH | US$0.03 | -22.0% | 49.6% | US$9.0m | US$0.23 | PS0.9x | E138.6% | n/a | ||
WDAY | US$265.39 | -4.7% | -2.6% | US$72.6b | US$292.30 | PE43.6x | E10.6% | n/a | ||
AI | US$35.46 | -17.4% | 23.4% | US$4.7b | US$36.15 | PS13.2x | E-11.1% | n/a | ||
CXM | US$8.99 | -4.6% | -24.3% | US$2.3b | US$10.21 | PE51.9x | E21.1% | n/a | ||
LAW | US$5.20 | -11.6% | -32.2% | US$311.5m | US$6.67 | PS2.2x | E7.8% | n/a | ||
VERB | US$6.02 | -9.2% | -82.3% | US$6.0m | US$100.00 | PS29.7x | E2.3% | n/a | ||
LVWD | US$0.14 | -9.7% | -18.1% | US$7.1m | n/a | PS0.6x | n/a | n/a | ||
BRZE | US$43.43 | -3.0% | -19.7% | US$4.6b | US$52.50 | PS8x | E12.8% | n/a | ||
RAMP | US$30.69 | -5.2% | -18.2% | US$2.0b | US$37.14 | PE1387.1x | E64.7% | n/a | ||
PHUN | US$4.41 | 1.8% | 8.9% | US$77.4m | US$12.75 | PS24.8x | E66.6% | n/a | ||
PCOR | US$76.54 | -1.5% | 10.3% | US$11.4b | US$82.12 | PS10.3x | E14.2% | n/a | ||
DMRC | US$37.49 | 5.6% | 3.2% | US$790.3m | US$34.00 | PS20.6x | E13.0% | 0% | ||
PAYD | US$2.65 | 5.6% | 112.0% | US$21.4m | n/a | PE13.6x | n/a | n/a | ||
AIFS | US$1.45 | 0% | -27.5% | US$6.8m | n/a | PE30.6x | n/a | 0% | ||
ARBB | US$0.39 | -16.2% | -59.1% | US$10.8m | n/a | PS0.8x | n/a | n/a | ||
TEAM | US$251.40 | -9.6% | 4.4% | US$67.0b | US$271.60 | PS14.3x | E58.4% | n/a | ||
IFBD | US$2.11 | -0.5% | -73.9% | US$4.5m | n/a | PS14x | n/a | n/a | ||
RDCM | US$11.87 | 0.5% | 47.5% | US$186.2m | US$16.00 | PE25.4x | S10.7% | n/a | ||
OKTA | US$83.60 | -1.4% | -6.4% | US$14.3b | US$103.58 | PS5.7x | E37.3% | n/a | ||
RSKD | US$4.68 | -3.3% | 2.2% | US$761.2m | US$5.59 | PS2.4x | E66.6% | n/a |